An infectious illness caused by hepatitis B virus which causes an inflammation of the liver of hominoidea, including humans.
1Gilead said chronic hepatitis B affects more than 400 million people worldwide.
2Conclusions: Entecavir therapy showed excellent efficacy in nucleoside-naive chronic hepatitis B patients.
3Liver function tests were not a good predictor of hepatitis B infection.
4No one of the remaining patients showed hepatitis B virus reverse seroconversion.
5And expression unit containing hepatitis B virus PreC-C was cloned into it.
6Its transmission is essentially parenteral and resembles that of hepatitis B virus.
7Crescentic glomerulonephritis was diagnosed in two chronic hepatitis B surface antigen carriers.
8Conclusions: An increased prevalence of celiac disease was observed among hepatitis B patients.
9Objective: There are an estimated 350 million hepatitis B carriers worldwide.
10The recombinant hepatitis B vaccines available today are safe and immunogenic.
11One patient with recurrent hepatitis B developed chronic severe hepatitis B despite treatment.
12A fifth chimpanzee, without active hepatitis B virus infection, served as a control.
13Objective: To obtain an overview of rheumatic disorders occurring after hepatitis B vaccination.
14So far, hepatitis B virus cannot be grown in tissue cultures.
15Improvements in hepatitis B vaccination should be strongly encouraged by all healthcare systems.
16All patients were positive for anti-HCV and negative for hepatitis B surface antigen.
Translations for hepatitis B